Biosyent Financial Statements From 2010 to 2025

RX Stock  CAD 11.20  0.40  3.70%   
Biosyent financial statements provide useful quarterly and yearly information to potential Biosyent investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Biosyent financial statements helps investors assess Biosyent's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Biosyent's valuation are summarized below:
Gross Profit
27.4 M
Profit Margin
0.206
Market Capitalization
126.2 M
Enterprise Value Revenue
3.176
Revenue
34.5 M
There are over one hundred nineteen available fundamental signals for Biosyent, which can be analyzed over time and compared to other ratios. All traders should should validate Biosyent's prevailing fundamental trends against the trends from 2010 to 2025 to make sure the company is sustainable. Market Cap is likely to climb to about 101.1 M in 2025. Enterprise Value is likely to climb to about 94.7 M in 2025

Biosyent Total Revenue

38.15 Million

Check Biosyent financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biosyent's main balance sheet or income statement drivers, such as Depreciation And Amortization of 549.8 K, Total Revenue of 38.1 M or Gross Profit of 30.4 M, as well as many indicators such as Price To Sales Ratio of 2.93, Dividend Yield of 0.0094 or PTB Ratio of 3.7. Biosyent financial statements analysis is a perfect complement when working with Biosyent Valuation or Volatility modules.
  
This module can also supplement various Biosyent Technical models . Check out the analysis of Biosyent Correlation against competitors.

Biosyent Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets50.1 M47.8 M24.7 M
Slightly volatile
Short and Long Term Debt Total1.2 M1.4 M1.6 M
Very volatile
Other Current Liabilities228.7 K124.6 K248.5 K
Pretty Stable
Total Current Liabilities6.7 M6.4 M3.3 M
Slightly volatile
Total Stockholder Equity42 M40 M20.7 M
Slightly volatile
Property Plant And Equipment Net1.7 M1.7 M918.3 K
Slightly volatile
Accounts Payable6.1 M5.8 M2.9 M
Slightly volatile
Cash5.4 M5.6 M8.6 M
Slightly volatile
Non Current Assets Total6.8 M6.5 M2.7 M
Slightly volatile
Cash And Short Term Investments31.6 M30.1 M17.2 M
Slightly volatile
Common Stock Shares Outstanding13.5 M14 M13.3 M
Pretty Stable
Liabilities And Stockholders Equity50.1 M47.8 M24.7 M
Slightly volatile
Inventory7.1 M6.8 M2.4 M
Slightly volatile
Other Current Assets163.3 K280 K211.4 K
Slightly volatile
Other Stockholder Equity3.1 M2.1 M1.8 M
Pretty Stable
Total Liabilities8.2 M7.8 MM
Slightly volatile
Total Current Assets43.3 M41.3 M22 M
Slightly volatile
Short Term Debt171.5 K165 K156.6 K
Slightly volatile
Intangible Assets1.4 M1.3 M901.5 K
Slightly volatile
Net Receivables4.3 M4.1 MM
Slightly volatile
Short Term Investments25.7 M24.5 M8.8 M
Slightly volatile
Common Stock5.4 M4.6 M6.5 M
Slightly volatile
Other Liabilities153.4 K209.7 K124.4 K
Slightly volatile
Net Tangible Assets21.9 M37.1 M19 M
Slightly volatile
Other Assets1.091.15330.7 K
Very volatile
Non Current Liabilities Total851.1 K1.4 M677.1 K
Slightly volatile
Property Plant Equipment961.5 K1.9 M839 K
Slightly volatile
Deferred Long Term Liabilities98.8 K196.2 K85.2 K
Slightly volatile
Net Invested Capital31.8 M40 M26.8 M
Slightly volatile
Net Working Capital29.1 M34.9 M24.4 M
Slightly volatile
Capital StockM4.6 M6.8 M
Slightly volatile
Capital Lease Obligations1.2 M1.1 M1.7 M
Slightly volatile
Property Plant And Equipment Gross3.5 M3.8 M3.2 M
Slightly volatile

Biosyent Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization549.8 K523.6 K252.4 K
Slightly volatile
Total Revenue38.1 M36.3 M19.4 M
Slightly volatile
Gross Profit30.4 M28.9 M15.3 M
Slightly volatile
Other Operating Expenses29 M27.7 M14.2 M
Slightly volatile
Cost Of Revenue7.8 M7.4 M4.1 M
Slightly volatile
Total Operating Expenses21.3 M20.2 M10.1 M
Slightly volatile
Interest Expense68.6 K78.7 K86.7 K
Pretty Stable
Research Development112.1 K95.8 K97 K
Slightly volatile
Selling General AdministrativeM11.2 M6.5 M
Slightly volatile
Selling And Marketing Expenses9.1 M8.7 MM
Slightly volatile
Net Income From Continuing OpsM7.4 M4.3 M
Slightly volatile
Net Income Applicable To Common Shares4.8 M6.3 M4.1 M
Slightly volatile
Tax Provision1.9 M2.4 M1.7 M
Slightly volatile
Net Interest Income1.3 M1.2 M370.2 K
Slightly volatile
Interest Income1.4 M1.3 M402.5 K
Slightly volatile
Reconciled Depreciation399.2 K523.6 K299.4 K
Slightly volatile

Biosyent Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow5.1 M6.1 M8.2 M
Slightly volatile
Depreciation549.8 K523.6 K252.4 K
Slightly volatile
Capital Expenditures3.2 M3.1 M850.7 K
Slightly volatile
End Period Cash Flow5.4 M5.6 M8.6 M
Slightly volatile
Stock Based Compensation620 K590.5 K268.7 K
Slightly volatile
Change To Netincome112.8 K118.7 K288.5 K
Slightly volatile
Dividends Paid2.3 M2.2 M435.7 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.933.055.2019
Slightly volatile
Dividend Yield0.00940.01610.0073
Slightly volatile
PTB Ratio3.72.776.291
Slightly volatile
Days Sales Outstanding83.5347.1240.2571
Slightly volatile
Book Value Per Share2.752.621.5132
Slightly volatile
Average Payables2.2 M2.1 M1.8 M
Slightly volatile
Stock Based Compensation To Revenue0.01030.01460.0132
Very volatile
Capex To Depreciation0.330.342.7251
Slightly volatile
PB Ratio3.72.776.291
Slightly volatile
EV To Sales2.62.854.7545
Slightly volatile
Inventory Turnover1.111.172.4605
Slightly volatile
Days Of Inventory On Hand339323191
Slightly volatile
Payables Turnover1.291.061.465
Pretty Stable
Sales General And Administrative To Revenue0.480.350.4169
Slightly volatile
Average Inventory1.7 M1.6 M1.2 M
Slightly volatile
Research And Ddevelopement To Revenue0.00420.00270.0049
Pretty Stable
Capex To Revenue0.0060.00630.0265
Slightly volatile
Cash Per Share2.071.971.2622
Slightly volatile
Payout Ratio0.150.270.1168
Slightly volatile
Days Payables Outstanding303356273
Very volatile
Income Quality0.590.70.9942
Pretty Stable
Intangibles To Total Assets0.03030.03190.0484
Slightly volatile
Current Ratio3.915.835.7794
Slightly volatile
Tangible Book Value Per Share2.662.531.4467
Slightly volatile
Receivables Turnover11.9810.2410.5776
Very volatile
Graham Number5.625.353.2341
Slightly volatile
Shareholders Equity Per Share2.752.621.5132
Slightly volatile
Debt To Equity0.03840.04040.0822
Slightly volatile
Capex Per Share0.01280.01310.024
Very volatile
Average Receivables1.6 M1.5 M1.3 M
Slightly volatile
Revenue Per Share2.52.381.4231
Slightly volatile
Interest Debt Per Share0.10.09710.0572
Slightly volatile
Debt To Assets0.03210.03380.0589
Slightly volatile
Operating Cycle231460221
Slightly volatile
Price Book Value Ratio3.72.776.291
Slightly volatile
Days Of Payables Outstanding303356273
Very volatile
Dividend Payout Ratio0.150.270.1168
Slightly volatile
Ebt Per Ebit1.081.031.0473
Slightly volatile
Company Equity Multiplier1.711.371.3213
Pretty Stable
Total Debt To Capitalization0.03710.0390.0716
Slightly volatile
Debt Equity Ratio0.03840.04040.0822
Slightly volatile
Quick Ratio3.434.885.2129
Slightly volatile
Net Income Per E B T0.940.870.8172
Slightly volatile
Cash Ratio2.071.32.9952
Very volatile
Days Of Inventory Outstanding339323191
Slightly volatile
Days Of Sales Outstanding83.5347.1240.2571
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.051.110.9505
Very volatile
Price To Book Ratio3.72.776.291
Slightly volatile
Fixed Asset Turnover35.0319.7444.069
Slightly volatile
Debt Ratio0.03210.03380.0589
Slightly volatile
Price Sales Ratio2.933.055.2019
Slightly volatile
Asset Turnover0.740.680.9194
Slightly volatile
Gross Profit Margin0.560.730.7563
Very volatile
Price Fair Value3.72.776.291
Slightly volatile

Biosyent Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap101.1 M96.3 M92.9 M
Slightly volatile
Enterprise Value94.7 M90.2 M84.1 M
Slightly volatile

Biosyent Fundamental Market Drivers

Forward Price Earnings14.0056
Cash And Short Term Investments26.2 M

About Biosyent Financial Statements

Biosyent investors use historical fundamental indicators, such as Biosyent's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biosyent. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue154.6 K138 K
Total Revenue36.3 M38.1 M
Cost Of Revenue7.4 M7.8 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.35  0.48 
Capex To Revenue 0.01  0.01 
Revenue Per Share 2.38  2.50 
Ebit Per Revenue 0.21  0.22 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Biosyent Stock Analysis

When running Biosyent's price analysis, check to measure Biosyent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosyent is operating at the current time. Most of Biosyent's value examination focuses on studying past and present price action to predict the probability of Biosyent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosyent's price. Additionally, you may evaluate how the addition of Biosyent to your portfolios can decrease your overall portfolio volatility.